Researchers have identified four gene mutations tied to aggressive stomach cancer, paving the way for more targeted ...

Cycuria aims to revolutionise treatment of hard-to-treat blood cancers with a first-in-class protein-based therapeutic approach specifically targeting both tumour cells and tumour stem cells·    ...

胰腺癌（PDAC）预后差，其免疫抑制微环境和患者营养状态影响治疗。研究人员整合全身免疫炎症指数（SII）和预后营养指数（PNI）评估免疫营养状态，发现 SPS+患者生存结局差、PD-L1 高表达、p53 突变不同，为 PDAC 治疗提供新方向。

(NEPC). The findings enhance the understanding of the treatment of androgen receptor functions in NEPC. Neuroendocrine prostate cancer (NEPC) arises primarily through neuroendocrine ...

Sydney: Medical researchers have developed advanced computational tools that significantly improve the accuracy of genetic ...

Patients with CLL and a CSHA CFS score greater than 3 had significantly higher rates of treatment interruption due to adverse effects.

May Overcome Resistance to Azacitidine-Venetoclax Regimen and Trigger Apoptosis of TP53 Mutated AML CellsNEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ...

A genetic signature including four genes in gastric cancer is linked to an increase in recurrence and mortality.

癌度医学临床招募资讯微信群（点击）在过去几十年时间里，表皮生长因子受体（EGFR）已经是非小细胞肺癌里最为常见的基因突变，在亚裔非小细胞肺腺癌里EGFR基因突变的概率在50%左右，其中19号外显子非移码缺失突变和21号外显子L858R点突变占比最高， ...

Research shows improved survival outcomes with statin use in patients with chronic lymphocytic leukemia receiving ibrutinib ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.